Project Details
Description
Selective Antibody and T cell Recognition of Citrullinated MBP in Rheumatoid Arthritis Patients Selective Antibody and T cell Recognition of Citrullinated MBP in Rheumatoid Arthritis Patients
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/15 → 2/29/16 |
Funding
- HHS-NIH: National Institute of Allergy & Infectious Diseases (NIAID): $54,075.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.